Charles Denby Put the Brewery’s Smallest Worker in Charge

The clue was hiding in the grocery bill for a homemade batch of beer. Charles Denby was spending his weekdays engineering yeast for next-generation biofuels in Jay Keasling’s UC Berkeley laboratory. On weekends, he was teaching himself to brew in a garage. Hops, he noticed, were by far the expensive part. Then his two worlds clicked together: some of the same aromatic molecules prized in hops could, in principle, be produced by the tiny living factories already doing the fermentation.

“That was the light bulb for me,” Denby later recalled. He imagined asking brewer’s yeast to make parts per billion of selected flavor compounds inside an otherwise ordinary fermentation. Less dependence on an agricultural input, more consistency from batch to batch, and no need to turn a brewhouse into a biotech facility. The intervention could be microscopic. The result would arrive in the glass.

First, learn the organism

Denby’s path to beer began with questions that had nothing to do with a taproom. At Whitman College he studied biophysics, biochemistry, and molecular biology. At UC Berkeley, where he earned a PhD in molecular and cellular biology in 2012, he examined how negative feedback makes yeast gene regulation robust to mutation. The work was basic science: understand how a cell preserves a useful response while the machinery underneath it changes.

That training gave him an unusually intimate view of yeast. A brewing strain is not a neutral packet sprinkled into wort. It senses, consumes, transforms, and leaves a trail of molecules that the drinker experiences as aroma, flavor, texture, and alcohol. Brewers have selected and handled these organisms for centuries, often without seeing the circuitry that modern genetics can now reveal.

After the doctorate, Denby joined Keasling’s group as a postdoctoral researcher. The lab was known for metabolic engineering: redirecting the biochemical traffic inside cells so that yeast could manufacture useful compounds. Denby worked on fuels. Rachel Li, a fellow researcher who would become his co-founder, was there too. When Denby recognized that terpenes made in lab yeast included compounds behind the citrus character of hoppy beer, the garage hobby stopped looking like recreation and started looking like a test market.

A paper you could taste

Denby and Li began exploring yeast that could make hop-associated aromas during fermentation. They recruited another Berkeley scientist and homebrewer, Nick Harris, and founded the company now called Berkeley Yeast. Their pivotal 2018 paper described industrial brewing strains engineered to produce linalool and geraniol, two central determinants of hoppy aroma. Genetic material associated with yeast, mint, and basil helped build and tune the pathways. Lagunitas participated in sensory analysis.

The result had a rare quality for an academic demonstration: it was legible without a microscope. People could taste it. Beer fermented with the engineered strains, but without conventional aroma hops, could present a hoppy character. The paper also framed hops as a variable, water- and energy-intensive crop. A cell that produced precise aroma molecules might offer consistency and use fewer resources.

“We give brewers more of the flavors they want and less of the flavors they don’t want.”Charles Denby

Then the market edited the idea

The first reaction was not simply applause. Some hop growers heard an existential threat. Some traditionalists saw a technology company trying to subtract agriculture and craft from an old cultural object. Even brewers who understood the science did not necessarily wake up wanting hops removed from beer. A striking technical result had collided with a network of farmers, recipes, identities, and rituals.

Berkeley Yeast responded with an exercise that was less glamorous than CRISPR and more consequential for the company. The founders interviewed more than 100 brewers and asked what their dream strain would do. The answers redirected the product. Brewers wanted to solve daily problems: emphasize a particular aroma, avoid an unwanted flavor, sour a beer without an extra process, produce a more convincing non-alcoholic beer, or make the same good result reliably.

The company’s posture shifted from replacement toward collaboration. Its Tropics strains, for example, are designed to free tropical-fruit thiols from otherwise flavorless precursors in malt and hops. Hops remain in the conversation; yeast helps reveal more of what is already there. Another strain prevents formation of diacetyl, the buttery off-flavor that can force a brewery to wait while yeast cleans up after itself.

That distinction is the hinge of Denby’s founder story. Synthetic biology supplies an astonishing menu of possible interventions. A customer supplies the definition of useful. The discipline is not proving that a cell can do something unusual. It is choosing the unusual thing that fits into somebody else’s demanding, time-sensitive production system.

When the yeast gets carried away

Biology also has its own opinions. Denby once described an early attempt at a souring yeast: the team inserted a souring gene, and it performed too well. The pH plunged below 3 so quickly that the yeast could not finish fermentation. The strain had achieved the specified action and failed the larger job. Berkeley Yeast had to tune it for controlled acidification.

It is a neat parable for the entire company. A pathway never exists alone. Neither does a product. A great brewery ingredient must work with temperature, timing, raw materials, equipment, staff, regulation, and the sensory expectations attached to a style. The laboratory asks whether a modification works. The brewery asks whether everything still works.

The business needed an equally patient chain of support. Denby has said that before starting the company, he believed metabolic engineering could reshape fermented beverages but found quitting his job without financing too risky. An NSF small-business grant provided what he called the “activation energy” to move from experiment to startup. Other federal grants and private investment followed. In 2023, Berkeley Yeast raised a reported $10.5 million Series A.

The quiet proof is paperwork

For a food-biotechnology founder, progress sometimes looks like a regulatory letter. In March 2026, the US Food and Drug Administration completed its evaluation of a notice concerning Berkeley Yeast strain BY-927. The strain expresses an enzyme intended to prevent diacetyl from forming during beer production. The agency said it had no questions at that time about the company’s conclusion that the intended use was generally recognized as safe. The underlying submission covers construction, manufacturing, batch analysis, and exposure, the unromantic details that turn a clever organism into a serious ingredient.

The company has also pushed into non-alcoholic brewing. Traditional dealcoholization can require extra equipment and energy, while some maltose-negative wild yeasts make little alcohol but bring flavors or behavior that brewers do not want. Berkeley Yeast has worked from domesticated brewing backgrounds, aiming to limit fermentation while preserving recognizable beer character. In 2025, Denby signed a regulatory notice for a strain intended to produce beer below 0.5 percent alcohol by volume. In April 2026, he and Harris co-authored a technical comparison of yeast approaches for non-alcoholic beer.

The laboratory asks whether a modification works. The brewery asks whether everything still works.

The scale hidden inside a glass

Berkeley Yeast has grown from garage logic and academic prototypes into a company supplying breweries and wineries. In 2025 it moved into a 9,500-square-foot San Leandro facility combining offices, research space, and a pilot brewery. The move makes physical what Denby’s career has been doing all along: shortening the distance among gene, tank, and taste.

His own range extends beyond the lab. A Master Brewers biography puts him climbing in Yosemite, skiing in the backcountry, and descending remote Cascade canyons. Those pursuits reward preparation but retain uncertainty, a reasonable off-hours match for engineering living systems. The cell, the mountain, and the fermenter all punish the fantasy of total control.

Denby’s larger aspiration is expressed by the company as doing more with less: less reliance on resource-intensive crops, fewer energy-heavy process steps, tighter control over quality. The phrase risks abstraction until it is attached to a brewery task. More tropical aroma from the ingredients already in the tank. Less time waiting for diacetyl to disappear. A sour fermentation without a separate kettle-souring routine. Non-alcoholic beer that still reads as fermented rather than merely sweet.

There is no single future of beer hiding in a DNA sequence. There are thousands of brewers making choices, drinkers noticing or not noticing, growers adapting, and regulators checking the evidence. Denby’s contribution is a new set of choices. He began with the thought that yeast might replace part of an ingredient. He built a company by discovering that the more durable opportunity was to make yeast a better collaborator.